Hollywood, FL – It’s tee time for the 35th Annual Don Strock Diabetes Golf Classic, one of the longest running and most successful celebrity/amateur charity golf tournaments in the South Florida community.
The tourney on Wednesday, May 9, 2018 is hosted by former Miami Dolphins quarterback Don Strock and chaired by philanthropist and retired produce company owner Bruce Fishbein at the Miccosukee Golf and Country Club, 6401 Kendale Lakes Drive, in Miami.
The Don Strock Diabetes Golf Classic has raised more than $3 million for the Diabetes Research Institute (DRI) and its mission to find a biological cure for diabetes.
Participants will join celebrity and amateur golfers first for lunch and then a shotgun tee off at Noon. After completing the picturesque and challenging course, players enjoy a cocktail hour and awards dinner including an exciting live and silent auction to benefit the DRI.
Each year, the event is largely sponsored by Fishbein’s former colleagues in the South Florida produce business and shipping industries including GPS Global Perishable Services, LLP; King Ocean Services; Premier Produce; Sotolongo Farms; M & R Produce Distributors; Mr. Greens Produce; Sierra Produce; Quality First Produce; Tropical Shipping; Pine Island Tomato Farms; Aloha Freightways; Crystal Valley Foods; and HapCor.
For more information, visit DiabetesResearch.org/Don-Strock-Diabetes-Golf-Classic or contact Nicole Otto atnotto@drif.org or 954-964-4040.
About the Diabetes Research Institute and Foundation
The mission of the Diabetes Research Institute Foundation is to provide the Diabetes Research Institute with the funding necessary to cure diabetes now. The Diabetes Research Institute at the University of Miami Miller School of Medicine leads the world in cure-focused research. As the largest and most comprehensive research center dedicated to curing diabetes, the DRI is aggressively working to develop a biological cure by restoring natural insulin production and normalizing blood sugar levels without imposing other risks. Researchers have already shown that transplanted islet cells allow patients to live without the need for insulin therapy. Some study participants have maintained insulin independence for more than 10 years. The DRI is now building upon these promising outcomes by developing a DRI BioHub, a bioengineered “mini organ” that mimics the native pancreas. While various BioHub platforms are being tested in preclinical and clinical studies, the DRI is also developing strategies to eliminate the need for anti-rejection drugs and reset the immune system to block autoimmunity. For more information, please visitDiabetesResearch.org, tweet @Diabetes_DRI or call 212-888-2217.
Source: Diabetes Research Institute and Foundation
